Back to Search
JAMES SOSMAN, MD
MD
Internal Medicine Physician
NPI: 1831150291IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35644(WI)
Infectious Disease Physician
Internal Medicine — Infectious Disease
Code: 207RI0200X
35644(WI)
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1985
Research & Publications (20)
Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability.
PMID 15825246·Int J STD AIDS·2005
8-other
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
PMID 19402064·Cancer·2009
8-other
Phase I/II trial of tremelimumab in patients with metastatic melanoma.
PMID 19139427·J Clin Oncol·2009
3-trial
Inside life of melanoma cell signaling, molecular insights, and therapeutic targets.
PMID 19679016·Curr Oncol Rep·2009
6-review
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
PMID 18445842·J Clin Oncol·2008
3-trial
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.
PMID 18463792·Invest New Drugs·2008
3-trial
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
PMID 18467720·J Clin Oncol·2008
3-trial
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431).
PMID 18483359·Clin Cancer Res·2008
8-other
Prevention strategies for cardiovascular disease in HIV-infected patients.
PMID 18566315·Circulation·2008
8-other
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.
PMID 19001327·J Clin Oncol·2008
3-trial
Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates.
PMID 17345144·AIDS Behav·2008
3-trial
Improving outcomes in patients with advanced renal cell carcinoma.
PMID 18366295·Expert Rev Anticancer Ther·2008
6-review
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
PMID 18669461·J Clin Oncol·2008
3-trial
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
PMID 18792064·Cancer·2008
3-trial
Young incarcerated men's perceptions of and experiences with HIV testing.
PMID 17538063·Am J Public Health·2007
8-other
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
PMID 17538086·N Engl J Med·2007
3-trial
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.
PMID 17545537·Clin Cancer Res·2007
3-trial
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses.
PMID 17699863·Clin Cancer Res·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2880 UNIVERSITY AVE
MADISON, WI 53705 - Phone
- (608) 263-7500
Quick Facts
- NPI
- 1831150291
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile